{"id":"W2060821918","doi":"10.1016/j.yebeh.2014.09.061","title":"Efficacy of once-daily extended-release topiramate (USL255): A subgroup analysis based on the level of treatment resistance","year":2014,"lang":"en","type":"article","venue":"Epilepsy & Behavior","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"UCB Pharma; H. Lundbeck A/S; Upsher-Smith; SK Life Science; Valeant Pharmaceuticals International; Eisai; Sunovion","keywords":"Topiramate; Medicine; Placebo; Drug Resistant Epilepsy; Clinical endpoint; Clinical Global Impression; Epilepsy; Subgroup analysis; Internal medicine; Post-hoc analysis; Drug; Adjunctive treatment; Clinical trial; Anesthesia; Pharmacology; Psychiatry; Meta-analysis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004344433,0.0003182839,0.0008398641,0.0003274923,0.0001130769,0.00001646214,0.0002283355,0.0001044324,0.0006374496],"category_scores_gemma":[0.0002804215,0.0001937391,0.0007100856,0.0007911994,0.0002571326,0.00003723484,0.00003094843,0.0001837242,0.00004448626],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000312984,"about_ca_system_score_gemma":0.000235561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006207616,"about_ca_topic_score_gemma":0.0004270649,"domain_scores_codex":[0.9974084,0.0002881725,0.0006007067,0.0004847316,0.0007090187,0.0005089652],"domain_scores_gemma":[0.9971128,0.0006713443,0.0002721503,0.001405346,0.0002122655,0.0003260789],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005301029,0.01265972,0.890586,0.0001416335,0.00157243,0.0001976655,0.000492076,0.0001598149,0.01052603,0.002021198,0.0008482988,0.07549416],"study_design_scores_gemma":[0.005527947,0.003565746,0.9642784,0.0001532828,0.003019314,0.000001840719,0.00006138973,0.0007504889,0.02136236,0.0000181359,0.00109629,0.0001647775],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995074,0.0001223813,0.0002926422,0.0009063189,0.0000476347,0.001153165,0.0002039531,0.00003964425,0.00216026],"genre_scores_gemma":[0.9949046,0.00005854161,0.001078775,0.0001210606,0.00006054365,0.0003497144,0.0001149101,0.00003252627,0.003279379],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07532938,"threshold_uncertainty_score":0.7900453,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06200573374235775,"score_gpt":0.3327966102095909,"score_spread":0.2707908764672332,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}